ROIV · Roivant Sciences Ltd.

$36.30 -0.54 (-1.47%) At close · Aug 21

Market Cap

$26.22B

722.32M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-06	2026-06-30
8-K	2026-08-06	—
DEF 14A	2026-07-29	2026-09-16
Investor Event Transcript	2026-06-09	2025-09-30
Investor Event Transcript	2026-06-03	2025-09-30
Investor Event Transcript	2026-05-29	2025-09-30
8-K	2026-05-20	—
10-K	2026-05-20	2026-03-31
8-K	2026-04-02	—
8-K/A	2026-03-23	2026-03-03
8-K	2026-03-03	—
8-K	2026-03-03	—
10-Q	2026-02-06	2025-12-31
8-K	2026-02-06	—
8-K	2025-12-11	—
10-Q	2025-11-10	2025-09-30
8-K	2025-11-10	—
8-K	2025-09-17	—
8-K	2025-09-11	2025-09-10
8-K	2025-09-03	—
10-Q	2025-08-11	2025-06-30
8-K	2025-08-11	—
DEF 14A	2025-07-29	2025-09-10
8-K	2025-06-25	2025-06-24
8-K	2025-05-29	—
10-K	2025-05-29	2025-03-31
8-K	2025-04-21	—
8-K	2025-03-20	2025-03-16
8-K	2025-03-19	—
8-K	2025-02-21	2025-02-19
8-K	2025-02-10	—
10-Q	2025-02-10	2024-12-31
8-K	2024-12-03	—
10-Q	2024-11-12	2024-09-30
8-K	2024-11-12	—
8-K	2024-10-28	—
8-K	2024-09-23	2024-09-17
8-K	2024-09-18	—
8-K	2024-09-16	2024-09-10
8-K	2024-09-10	—
8-K	2024-09-09	—
10-Q	2024-08-09	2024-06-30
8-K	2024-08-08	—
DEF 14A	2024-07-26	2024-09-10
8-K	2024-05-30	—
10-K	2024-05-30	2024-03-31
8-K	2024-05-30	2024-05-24
8-K	2024-04-02	—
10-Q	2024-02-13	2023-12-31
8-K	2024-02-13	—

Showing 1–50 of 106 filings

Key facts CIK 1635088 CUSIP G76279101 13F (30d) 440 filings 422 filers Visit website Investor relations